Purchases and Sales Made in Q1 2022 in Clarus Therapeutics Hldgs Inc (CRXTQ)
This table provides information about the institutional ownership of Clarus Therapeutics Hldgs Inc (CRXTQ) during Q1 2022. The information is specifically focused on institutions that hold shares of CLARUS THERAPEUTICS HLDGS INC .
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 16, 2022
Q1 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
90KNew |
N/A
|
90K
$0
|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
34.7KNew |
N/A
|
34.7K
$0
|
|
May 13, 2022
Q1 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
33.9KNew |
N/A
|
33.9K
$0
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
BUY
|
- |
20.9K+ 45.82% |
N/A
|
66.5K
$0
|
|
May 17, 2022
Q1 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
20.4KNew |
N/A
|
20.4K
$0
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
BUY
|
- |
7.4KNew |
N/A
|
7.4K
$0
|
|
May 16, 2022
Q1 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
500New |
N/A
|
500
$0
|
|
May 16, 2022
Q1 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
15+ 60.0% |
N/A
|
40
$0
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2Closed |
N/A
|
0
$0
|
|
May 12, 2022
Q1 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-8.99K- 69.54% |
N/A
|
3.94K
$0
|
|
May 16, 2022
Q1 2022
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-18.1KClosed |
N/A
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-20.8KClosed |
N/A
|
0
$0
|
|
May 09, 2022
Q1 2022
|
Powell Investment Advisors, LLC
|
SELL
|
- |
-64KClosed |
N/A
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.93MClosed |
N/A
|
0
$0
|